trial
as of 2026-07-01Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia
NCTId NCT01032083
at a glance
Phase 4 · Completed
Enrollment 62 (actual)
Sponsored by Imperial College London
Primary completion 2014-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
62 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2011-07
Primary completion
2014-12
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Drugs
Indications
Sponsors
Imperial College LondonLead Sponsor
University of ManchesterCollaborator
University of SouthamptonCollaborator
King's College LondonCollaborator
University of OxfordCollaborator
University College, LondonCollaborator
University of BristolCollaborator
Investigators
1
Thomas R Barnes, MDPrincipal Investigator
Sites
14 total
Bristol, United KingdomDerby, United KingdomLincoln, United KingdomLondon, United KingdomLondon, United KingdomLondon, United KingdomLondon, United KingdomLondon, United KingdomManchester, United KingdomNewcastle, United KingdomOxford, United KingdomSheffield, United Kingdom
Facts & assertions
4 sourced
Enrollment
62
Phase
PHASE4
Primary Completion Date
2014-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
collaborator
company
company
indication
indication
indication
investigator
person